2.58% -0.00985

Theriva Biologics Inc (TOVX)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Theriva Biologics Inc Stock (TOVX) Company Profile

Theriva Biologics Inc

Healthcare (1107)

Biotechnology (615)

301 417 4364

9605 Medical Center Drive, Suite 270, Rockville

Nächster Verdiensttermin

Neueste SEC-Einreichungen

TOVX's Discussions on Twitter

Compare TOVX vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
TOVX Theriva Biologics Inc	0.3703	17.44M	0	-23.74M	-16.70M	-4.0366
VRTX Vertex Pharmaceuticals Inc	425.27	107.87B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	720.83	73.63B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	811.95	49.42B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	302.88	40.20B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	314.73	33.06B	5.36B	287.73M	924.18M	2.5229

Theriva Biologics Inc Aktie (TOVX) Neueste Nachrichten

Finanzdaten der Theriva Biologics Inc-Aktie (TOVX)

Theriva Biologics Inc (TOVX)

Theriva Biologics Inc Stock (TOVX) Company Profile

Compare TOVX vs VRTX, REGN, ARGX, ALNY, ONC

Theriva Biologics Inc Aktie (TOVX) Neueste Nachrichten

Theriva Biologics, Inc. Q1 2026 10-Q Report: Financial Statements, Results, and Key Disclosures - Minichart

Theriva Biologics Reports FDA Alignment on VCN-01 Phase 3 Trial Design for Metastatic Pancreatic Cancer and Q1 2026 Financial Results - Minichart

Theriva™ Biologics Reports First Quarter 2026 Operational Highlights and Financial Results - The Manila Times

Theriva Biologics: Q1 Earnings Snapshot - marketscreener.com

Theriva Biologics (NYSE American: TOVX) posts Q1 loss, flags going concern risk - Stock Titan

Theriva Biologics (NYSE: TOVX) narrows Q1 loss and advances VCN-01 toward pivotal trials - Stock Titan

Theriva moves pancreatic cancer drug toward Phase 3, cash into 2027 - Stock Titan

TOVX Forecast, Price Target & Analyst Ratings | THERIVA BIOLOGICS INC (NYSEARCA:TOVX) - ChartMill

MSN Money - MSN

Warrant vote could unlock $8.7M for Theriva Biologics (TOVX) - Stock Titan

TOVX Stock Price, Quote & Chart | THERIVA BIOLOGICS INC (NYSEARCA:TOVX) - ChartMill

TOVX|Theriva Biologics Inc|Price:0.330|Chg%:-0.03 - TradingKey

Theriva Biologics (TOVX) price target decreased by 42.86% to 4.08 - MSN

Trending Stocks Today | Psyence Biomedical Soars 130.26% Pre-Market - Moomoo

Why is Theriva stock gaining Monday? - MSN

symbol__ Stock Quote Price and Forecast - CNN

TOVX Should I Buy - Intellectia AI

Press Releases about Theriva Biologics, Inc. Common Stock (NYSE:TOVX) - FinancialContent

Theriva Biologics posts 34.6% EPS beat, no revenueMeet Estimates - Cổng thông tin điện tử tỉnh Lào Cai

Theriva Biologics announces pricing of $7.5M public offering - MSN

Theriva Biologics (TOVX) Comprehensive Review | Theriva Biologics posts 34.6% EPS beat, no revenueBorrow Rate - Cổng thông tin điện tử tỉnh Lào Cai

TOVX (Theriva Biologics Inc.) posts narrower than expected Q4 2025 loss, shares rise four percent on upbeat investor sentiment.Popular Trader Picks - Cổng thông tin điện tử Tỉnh Sơn La

Trending Stocks Today | Theriva Biologics Soars 67.92% Post-Market - 富途牛牛

BIOLASE Inc (BIOL) - Minichart

Theriva Biologics (NYSE: TOVX) asks shareholders to OK 16.18M warrant shares for $8.7M - Stock Titan

$Theriva Biologics (TOVX.US)$ keep loading on each pullback - Moomoo

Theriva Biologics stock surges on AACR cancer trial data - Investing.com

Theriva Biologics (TOVX) Stock Jumps 63% After Pancreatic Cancer Trial Data Drops at AACR - MEXC Exchange

Theriva Biologics stock surges on AACR cancer trial data By Investing.com - Investing.com UK

$Theriva Biologics (TOVX.US)$ it might be a miracle - Moomoo

Is Theriva Biologics (TOVX) stock breaking out today (Investors Pile In) 2026-04-20IPO Watch - Cổng thông tin điện tử tỉnh Lào Cai

Why Is Theriva Stock Gaining Monday? - Benzinga

Theriva Biologics (TOVX) Stock Soars 63% on Promising Pancreatic Cancer Data from AACR - MoneyCheck

Theriva Biologics (TOVX) Shares Soar 63% on Promising Pancreatic Cancer Trial Results - parameter.io

Theriva Biologics (TOVX) Stock Soars 63% on Promising Pancreatic Cancer Trial Results - Blockonomi

$Theriva Biologics (TOVX.US)$ added more to squeeze 🤞🏼🥳 - Moomoo

Theriva Biologics Presents Positive VIRAGE Phase 2b Clinical Trial Data of VCN-01 for Metastatic Pancreatic Cancer at AACR 2026 - Minichart

Theriva™ Biologics anuncia la próxima presentación de datos adicionales del ensayo clínico VIRAGE de Fase 2b del VCN-01 para el cáncer de páncreas metastásico en la Reunión Anual de la AACR de 2026 - GlobeNewswire Inc.

Theriva Biologics (TOVX) Set to Present New Clinical Data at AAC - GuruFocus

$Theriva Biologics (TOVX.US)$ sell too fast wow - Moomoo

Theriva Biologics Highlights Positive VCN-01 Pancreatic Cancer Data - TipRanks

[8-K] Theriva Biologics, Inc. Reports Material Event - Stock Titan

Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting - GlobeNewswire

CEO Moves: Is Theriva Biologics Inc subject to activist investor interest2026 Momentum Check & Free High Return Stock Watch Alerts - baoquankhu1.vn

Theriva Biologics, Inc. (TOVX) Files Form 8-K with SEC – Company Details and Exchange Information as of April 2026 - Minichart

Theriva Biologics to reschedule stockholder meeting after lack of quorum By Investing.com - Investing.com Australia

Theriva Biologics to reschedule stockholder meeting after lack of quorum - Investing.com

Resistance Check: Is Theriva Biologics Inc in a long term uptrend2026 Rallies & Stock Market Timing Techniques - baoquankhu1.vn

Theriva Biologics Faces Delays in Warrant Approval Meeting - TipRanks

Theriva Bi Called Special Meeting Fails to Reach Quorum; Will Re‑call Meeting to Seek Approval for 16.18M Warrant Shares - TradingView

Theriva Biologics (NYSE American: TOVX) resets vote on 16,184,560 warrant shares - Stock Titan

Finanzdaten der Theriva Biologics Inc-Aktie (TOVX)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie TOVX